Patent 7354910 was granted and assigned to Seikagaku on April, 2008 by the United States Patent and Trademark Office.
An agent for treating inflammatory bowel diseases and an agent for preventing or improving symptoms accompanied by inflammatory bowel diseases, which each comprises hyaluronic acid or a pharmaceutically acceptable salt thereof as an active ingredient.